These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 25480109

  • 1. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.
    Trappanese DM, Liu Y, McCormick RC, Cannavo A, Nanayakkara G, Baskharoun MM, Jarrett H, Woitek FJ, Tillson DM, Dillon AR, Recchia FA, Balligand JL, Houser SR, Koch WJ, Dell'Italia LJ, Tsai EJ.
    Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109
    [Abstract] [Full Text] [Related]

  • 2. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
    Liu Y, Dillon AR, Tillson M, Makarewich C, Nguyen V, Dell'Italia L, Sabri AK, Rizzo V, Tsai EJ.
    J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
    [Abstract] [Full Text] [Related]

  • 3. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ, Liu Y, Koitabashi N, Bedja D, Danner T, Jasmin JF, Lisanti MP, Friebe A, Takimoto E, Kass DA.
    Circ Res; 2012 Jan 20; 110(2):295-303. PubMed ID: 22095726
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S, Radovits T, Barnucz E, Hirschberg K, Neugebauer P, Loganathan S, Veres G, Páli S, Seidel B, Zöllner S, Karck M, Szabó G.
    Circulation; 2009 Aug 25; 120(8):677-86. PubMed ID: 19667237
    [Abstract] [Full Text] [Related]

  • 5. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
    Pat B, Killingsworth C, Denney T, Zheng J, Powell P, Tillson M, Dillon AR, Dell'Italia LJ.
    Am J Physiol Heart Circ Physiol; 2008 Dec 25; 295(6):H2321-7. PubMed ID: 18849331
    [Abstract] [Full Text] [Related]

  • 6. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
    Angelone T, Filice E, Quintieri AM, Imbrogno S, Recchia A, Pulerà E, Mannarino C, Pellegrino D, Cerra MC.
    Acta Physiol (Oxf); 2008 Jul 25; 193(3):229-39. PubMed ID: 18208582
    [Abstract] [Full Text] [Related]

  • 7. β3-Adrenergic receptor blockade reduces mortality in endotoxin-induced heart failure by suppressing induced nitric oxide synthase and saving cardiac metabolism.
    Kawaguchi S, Okada M, Ijiri E, Koga D, Watanabe T, Hayashi K, Kashiwagi Y, Fujita S, Hasebe N.
    Am J Physiol Heart Circ Physiol; 2020 Feb 01; 318(2):H283-H294. PubMed ID: 31834837
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
    Feng MG, Prieto MC, Navar LG.
    Am J Physiol Renal Physiol; 2012 Sep 01; 303(5):F775-82. PubMed ID: 22674024
    [Abstract] [Full Text] [Related]

  • 9. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
    Imbrogno S, Angelone T, Adamo C, Pulerà E, Tota B, Cerra MC.
    J Exp Biol; 2006 Dec 01; 209(Pt 24):4966-73. PubMed ID: 17142685
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H.
    Kidney Int; 2005 Jul 01; 68(1):47-61. PubMed ID: 15954895
    [Abstract] [Full Text] [Related]

  • 11. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J, Wei CC, Hankes GH, Holland M, Rynders P, Dillon AR, Ardell JL, Armour JA, Lucchesi PA, Dell'Italia LJ.
    Circulation; 2003 Jul 15; 108(2):225-30. PubMed ID: 12847066
    [Abstract] [Full Text] [Related]

  • 12. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP, Cheng CY.
    Endocrinology; 2003 Jul 15; 144(7):3114-29. PubMed ID: 12810568
    [Abstract] [Full Text] [Related]

  • 13. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
    Cawley SM, Kolodziej S, Ichinose F, Brouckaert P, Buys ES, Bloch KD.
    Am J Physiol Heart Circ Physiol; 2011 Jul 15; 301(1):H157-63. PubMed ID: 21536853
    [Abstract] [Full Text] [Related]

  • 14. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H, Wang Y, Loof T, Martini S, Kron S, Krämer S, Neumayer HH.
    Kidney Int; 2004 Dec 15; 66(6):2224-36. PubMed ID: 15569311
    [Abstract] [Full Text] [Related]

  • 15. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D, Galuppo P, Motschenbacher S, Ruetten H, Schäfer A, Bauersachs J.
    Basic Res Cardiol; 2014 Jul 15; 109(4):421. PubMed ID: 24907870
    [Abstract] [Full Text] [Related]

  • 16. Metabolomics of repetitive myocardial stunning in chronic multivessel coronary artery stenosis: Effect of non-selective and selective β1-receptor blockers.
    Le DE, Alkayed NJ, Cao Z, Chattergoon NN, Garcia-Jaramillo M, Thornburg K, Kaul S.
    J Physiol; 2024 Jul 15; 602(14):3423-3448. PubMed ID: 38885335
    [Abstract] [Full Text] [Related]

  • 17. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 15; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 18. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
    Bice JS, Burley DS, Baxter GF.
    J Cardiovasc Pharmacol Ther; 2014 May 15; 19(3):269-82. PubMed ID: 24572031
    [Abstract] [Full Text] [Related]

  • 19. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.
    Sabri A, Rafiq K, Seqqat R, Kolpakov MA, Dillon R, Dell'italia LJ.
    Circ Res; 2008 May 09; 102(9):1127-36. PubMed ID: 18356543
    [Abstract] [Full Text] [Related]

  • 20. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M, Chrapusta SJ, Lukačova N, Langfort J.
    Brain Res; 2015 Aug 27; 1618():29-40. PubMed ID: 26006108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.